News & Updates
Filter by Specialty:

SGLT-2 inhibitors stop kidney stone recurrence in T2D patients with nephrolithiasis, gout
13 Nov 2024
byStephen Padilla
Use of an SGLT-2 inhibitor, compared with a GLP-1 receptor agonist or a DPP-4 inhibitor, helps to prevent nephrolithiasis from recurring in patients with type 2 diabetes (T2D) and pre-existing nephrolithiasis or gout, as shown in target trial emulation studies.